Press release
Revance Therapeutics, Inc. (NASDAQ: RVNC) Investor Alert: Deadline in Lawsuit on March 4, 2025
A Deadline is coming up on March 4, 2025 in the lawsuit for certain investors in Revance Therapeutics, Inc. (NASDAQ: RVNC).
Investors who purchased shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) have certain options and there are strict and short deadlines running. Deadline: March 4, 2025. Revance Therapeutics, Inc. (NASDAQ: RVNC) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Middle District of Tennessee the plaintiff alleges on behalf of purchasers of Revance Therapeutics, Inc. (NASDAQ: RVNC) common shares between February 29, 2024 and December 6, 2024, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between February 29, 2024 and December 6, 2024, the Defendants made false and/or misleading statements and/or failed to disclose that Revance was in material breach of the Distribution Agreement, thst the foregoing subjected the Company to an increased risk of litigation, as well as monetary and reputational harm, that all the foregoing increased the risk that the Tender Offer would be delayed and/or amended, and that as a result, the Company's public statements were materially false and misleading at all relevant times
Those who purchased shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Revance Therapeutics, Inc. (NASDAQ: RVNC) Investor Alert: Deadline in Lawsuit on March 4, 2025 here
News-ID: 3888992 • Views: …
More Releases from Shareholders Foundation, Inc.
Ready Capital Corporation (NYSE: RC) Long Term Investor Investigation of potenti …
An investigation was announced for potential breaches of fiduciary duties by certain directors and officers of Ready Capital Corporation.
Investors who are current long term investors in Ready Capital Corporation (NYSE: RC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NYSE: RC stocks follows a lawsuit filed against Ready…
Investigation announced for Long-Term Investors in shares of Digimarc Corporatio …
An investigation was announced for current long-term investors in shares of Digimarc Corporation (NASDAQ: DMRC) concerning potential breaches of fiduciary duties by certain directors of Digimarc Corporation.
Investors who are current long term investors in Digimarc Corporation (NASDAQ: DMRC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: DMRC…
Ultra Clean Holdings, Inc. (NASDAQ: UCTT) Investor Alert: Deadline in Lawsuit on …
A deadline is coming up on May 23, 2025 in the lawsuit filed for certain investors of Ultra Clean Holdings, Inc. (NASDAQ: UCTT) over alleged securities laws violations by Ultra Clean Holdings, Inc.
Investors who purchased shares of Ultra Clean Holdings, Inc. (NASDAQ: UCTT) have certain options and there are strict and short deadlines running. Deadline: May 23, 2025. Ultra Clean Holdings, Inc. (NASDAQ: UCTT) stockholders should contact the Shareholders…
Lawsuit filed for Investors who lost money with shares of West Pharmaceutical Se …
An investor, who purchased shares of West Pharmaceutical Services, Inc. (NYSE: WST), filed a lawsuit in the U.S. District Court for the Eastern District of Pennsylvania over alleged violations of Federal Securities Laws by West Pharmaceutical Services, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of West Pharmaceutical Services, Inc. (NYSE: WST) have certain options and for certain investors are short and strict deadlines running.…
More Releases for Revance
Investigation announced for Investors in Revance Therapeutics, Inc. (NASDAQ: RVN …
An investigation was announced for long-term investors in shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) concerning potential breaches of fiduciary duties by certain directors and officers of Revance Therapeutics, Inc.
Investors who are current long term investors in Revance Therapeutics, Inc. (NASDAQ: RVNC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Deadline on Feb. 8th coming up in Lawsuit for INvestros in Revance Therapeutics, …
A deadline is coming up on February 8, 2022 in the lawsuit filed for certain investors of Revance Therapeutics, Inc. (NASDAQ: RVNC) over alleged securities laws violations by Revance Therapeutics, Inc.
Investors who purchased shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) have certain options and there are strict and short deadlines running. Deadline: February 8, 2022. NASDAQ: RVNC stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
Lawsuit filed for Investors in shares of Revance Therapeutics, Inc. (NASDAQ: RVN …
An investor in shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) filed a lawsuit over alleged Securities Laws violations by Revance Therapeutics, Inc.
Investors who purchased shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) have certain options and for certain investors are short and strict deadlines running. Deadline: February 8, 2022. NASDAQ: RVNC investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Newark, CA based Revance Therapeutics, Inc.,…
Investigation for Investors in NASDAQ: RVNC shares over possible Wrongdoing at R …
Certain directors of Revance Therapeutics, Inc. are under investigation over potential breaches of fiduciary duties.
Investors who purchased shares of Revance Therapeutics, Inc. (NASDAQ: RVNC have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Revance Therapeutics, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
Newark, CA based Revance Therapeutics,…
Palmer Hyperhidrosis Treatment Market Research Report (2021-2027): Key Trends an …
Hyperhidrosis is a disorder that results in excessive sweating of palms, soles, or underarms. Palmer hyperhidrosis is excessive and uncontrollable hand sweating and is the most common type of hyperhidrosis. The sweating may range from mild to severe. Market Snapshot A recently published report by QY Research, titled “Global Palmer Hyperhidrosis Treatment Market Size, Status and Forecast 2022” gives an overview of the overall Palmer Hyperhidrosis Treatment market. This section…
Investigation announced for Investors in shares of Revance Therapeutics, Inc. (N …
An investigation was announced over potential securities laws violations by Revance Therapeutics, Inc. in connection with certain financial statements.
Investors who purchased shares of Revance Therapeutics, Inc. (NASDAQ: RVNC), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Revance Therapeutics, Inc. regarding its business, its prospects and its operations were…
